Survival, Prognosis, and Clinical Feature of Refractory Myasthenia Gravis: a 15-year Nationwide Cohort Study

BACKGROUND: Myasthenia gravis (MG) is a rare classic autoimmune disease where immunosuppressant therapies have been successful to reduce MG attributable mortality fairly well. However, patients with refractory MG (rMG) among the actively treated MG (aMG) are nonresponsive to conventional therapy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Sohyun, Noh, Yunha, Oh, In-Sun, Hong, Yoon-Ho, Shin, Ju-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506414/
https://www.ncbi.nlm.nih.gov/pubmed/34636500
http://dx.doi.org/10.3346/jkms.2021.36.e242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506414/
https://www.ncbi.nlm.nih.gov/pubmed/34636500
http://dx.doi.org/10.3346/jkms.2021.36.e242

Ejemplares similares